国际呼吸杂志
國際呼吸雜誌
국제호흡잡지
INTERNATIONAL JOURNAL OF RESPIRATION
2013年
2期
144-148
,共5页
非小细胞肺癌%分子靶向治疗
非小細胞肺癌%分子靶嚮治療
비소세포폐암%분자파향치료
Non-small cell lung cancer%Molecular targeted therapy
肺癌是当今世界上严重威胁人类生命与健康的恶性肿瘤性疾病之一,每年有超过100万人死于肺癌.其发病率和病死率逐年增高,引起了越来越多研究者的关注.其中,非小细胞肺癌占肺癌总数的80％～85％.肺癌的分子靶向治疗成为新近研究的热点,是21世纪肺癌治疗最具希望的方法和策略,让人们看到了曙光.
肺癌是噹今世界上嚴重威脅人類生命與健康的噁性腫瘤性疾病之一,每年有超過100萬人死于肺癌.其髮病率和病死率逐年增高,引起瞭越來越多研究者的關註.其中,非小細胞肺癌佔肺癌總數的80％～85％.肺癌的分子靶嚮治療成為新近研究的熱點,是21世紀肺癌治療最具希望的方法和策略,讓人們看到瞭曙光.
폐암시당금세계상엄중위협인류생명여건강적악성종류성질병지일,매년유초과100만인사우폐암.기발병솔화병사솔축년증고,인기료월래월다연구자적관주.기중,비소세포폐암점폐암총수적80％～85％.폐암적분자파향치료성위신근연구적열점,시21세기폐암치료최구희망적방법화책략,양인문간도료서광.
Lung cancer is one of the most serious malignant diseases in the world.More than one million people die from lung cancer each year.And the mortality and morbidity of lung cancer are increasing year by year,which attracts the great attention of a number of researchers.Non-small cell lung cancer accounts for 80％ to 85 ％ of the total number of lung cancer.In recent years,molecular targeted therapy has become a focus of study for non-small cell lung cancer.This therapy is the most promising method and strategy of the treatment of lung cancer in the 21st century.
